All News #Library
Biotech
AdvanCell Showcases Phase 2 ADVC001 Data in Prostate Cancer
24 Feb 2026 //
BUSINESSWIRE
Advancell Receives Initial High-Activity Thorium-228 Delivery
08 Dec 2025 //
BUSINESSWIRE
AdvanCell Starts Phase 2 ADVC001 Trial for Prostate Cancer
02 Dec 2025 //
BUSINESSWIRE
Advancell`s 212Pb-Advc001 Shows Safety And Anti-Tumor Activity
18 Oct 2025 //
GLOBENEWSWIRE
Advancell Names Andrew Kay Chair Of Board
16 Oct 2025 //
GLOBENEWSWIRE
AdvanCell to present promising clinical trial results of ADVC001
12 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support